Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 7/2003

01-09-2003

Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States)

Authors: H. Furberg, R.C. Millikan, J. Geradts, M.D. Gammon, L.G. Dressler, C.B. Ambrosone, B. Newman

Published in: Cancer Causes & Control | Issue 7/2003

Login to get access
Metadata
Title
Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States)
Authors
H. Furberg
R.C. Millikan
J. Geradts
M.D. Gammon
L.G. Dressler
C.B. Ambrosone
B. Newman
Publication date
01-09-2003
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Cancer Causes & Control / Issue 7/2003
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1025682410937

Other articles of this Issue 7/2003

Cancer Causes & Control 7/2003 Go to the issue

OriginalPaper

Glycemic index and load and risk of upper aero-digestive tract neoplasms (Italy)

OriginalPaper

Prospective study of serum retinol, β-carotene, β-cryptoxanthin, and lutein/zeaxanthin and esophageal and gastric cancers in China

OriginalPaper

A vision for cancer incidence surveillance in the United States

OriginalPaper

A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)

OriginalPaper

Allergy and risk of breast cancer among young women (United States)

OriginalPaper

Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits